New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 10:43:48 Source:travelViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Devout Christian doctor, 68, who punched dementia
Next:OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
You may also like
- The unstoppable duo of Emma Stone and Yorgos Lanthimos
- Jeremy Clarkson leads emotional tributes as BBC Top Gear legend dies aged 80
- Haiti violence: Haitians scramble to survive as gang violence chokes capital
- Rosie Huntington
- Uber and Lyft say they'll stay in Minnesota after Legislature passes driver pay compromise
- I'm a nutritionist and here are my top tips to beat your sugar cravings for good
- Masters champ Scottie Scheffler posts a 63 and leads the RBC Heritage by 1 shot
- Cucho, Moreira score goals to help Crew play Timbers to 2
- Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift